Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Cardiomyopathy_Paediatric v1.3 ATP5PO Zornitza Stark Tag new gene name tag was added to gene: ATP5PO.
Cardiomyopathy_Paediatric v1.3 ATP5PO Zornitza Stark Marked gene: ATP5PO as ready
Cardiomyopathy_Paediatric v1.3 ATP5PO Zornitza Stark Gene: atp5po has been classified as Amber List (Moderate Evidence).
Cardiomyopathy_Paediatric v1.3 ATP5PO Zornitza Stark Classified gene: ATP5PO as Amber List (moderate evidence)
Cardiomyopathy_Paediatric v1.3 ATP5PO Zornitza Stark Gene: atp5po has been classified as Amber List (Moderate Evidence).
Cardiomyopathy_Paediatric v1.2 ATP5PO Zornitza Stark gene: ATP5PO was added
gene: ATP5PO was added to Cardiomyopathy_Paediatric. Sources: Literature
Mode of inheritance for gene: ATP5PO was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: ATP5PO were set to 40913360; 35621276
Phenotypes for gene: ATP5PO were set to mitochondrial complex V (ATP synthase) deficiency, nuclear type 7, MONDO:0957255
Review for gene: ATP5PO was set to AMBER
Added comment: PMID 40913360 and PMID 35621276 report 4 individuals from 3 families with homozygous splice variant c.87+3A>G in ATP5PO causing early‑onset hypertrophic cardiomyopathy, encephalopathy and hypotonia. The phenotype aligns with mitochondrial complex V (ATP synthase) deficiency, nuclear type 7.

AMBER rating as manifestation only linked to this one specific variant; founder effect?
Sources: Literature